Phase 1 Cannabis Use Disorder Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Psilocybin-assisted Treatment for Cannabis Use Disorder
Cannabis Use Disorder
Johns Hopkins University12 enrolled1 locationNCT06660381
Recruiting
Phase 1Phase 2
Mitigating PTSD-CUD After Sexual Assault
Cannabis Use DisorderPosttraumatic Stress Disorder
University of Nevada, Las Vegas68 enrolled6 locationsNCT05989841
Recruiting
Phase 1Phase 2
SCORE Emerging Adult Cannabis Use & Stress
Cannabis Use Disorder
Medical University of South Carolina148 enrolled1 locationNCT05885542
Recruiting
Phase 1
Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use
Depression, AnxietyAnxietyDepression - Major Depressive Disorder+1 more
Trustees of Dartmouth College15 enrolled1 locationNCT06920238
Recruiting
Phase 1
Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans
SchizophreniaCannabis Use Disorder
Yale University215 enrolled1 locationNCT06058702